Drugplain

APUREE Nailtific Maximum Strength Antifungal Patches PRO 1 g/1

APUREE Nailtific Maximum Strength Antifungal Patches PRO · PATCH · Guangzhou Meixi Biotechnology Co., Ltd

No Recall History
Plain English

APUREE Nailtific Maximum Strength Antifungal Patches PRO is a patch containing apuree nailtific maximum strength antifungal patches pro at 1 g/1, taken topical. Manufactured by Guangzhou Meixi Biotechnology Co., Ltd.

Key Facts

Brand Name
APUREE Nailtific Maximum Strength Antifungal Patches PRO
Generic Name
APUREE Nailtific Maximum Strength Antifungal Patches PRO
NDC Code (Product)
84167-416
Manufacturer
Guangzhou Meixi Biotechnology Co., Ltd
Strength
1 g/1
Dosage Form
PATCH
Route
TOPICAL
Marketing Status
Application #
M005
Marketing Start
05/11/2026

Recall History

No Recall History

Frequently Asked Questions

What is APUREE Nailtific Maximum Strength Antifungal Patches PRO used for?

APUREE Nailtific Maximum Strength Antifungal Patches PRO contains APUREE Nailtific Maximum Strength Antifungal Patches PRO. It is a patch taken topical. Consult your doctor for specific uses.

Is APUREE Nailtific Maximum Strength Antifungal Patches PRO a controlled substance?

APUREE Nailtific Maximum Strength Antifungal Patches PRO is not classified as a controlled substance by the DEA.

What is the generic name for APUREE Nailtific Maximum Strength Antifungal Patches PRO?

The generic name for APUREE Nailtific Maximum Strength Antifungal Patches PRO is APUREE Nailtific Maximum Strength Antifungal Patches PRO. There are no other listed brand versions of APUREE Nailtific Maximum Strength Antifungal Patches PRO.

What is the NDC code for APUREE Nailtific Maximum Strength Antifungal Patches PRO 1 g/1?

The NDC (National Drug Code) for APUREE Nailtific Maximum Strength Antifungal Patches PRO 1 g/1 is 84167-416, listed by Guangzhou Meixi Biotechnology Co., Ltd.

Product NDC

84167-416

Package NDC

84167-416-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)